Skip to main content
Fig. 3 | BMC Bioinformatics

Fig. 3

From: PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients

Fig. 3

PDXGEM prediction scores for trastuzumab in breast cancer patients by HER2 status. Distributional plot of PDXGEM prediction scores between patients with pathological complete response (pCR) and patients with residual of disease (RD) after receiving trastuzumab (a) in HER2 positive breast cancer patients, (b) in HER2 positive breast cancer patients who did not receive trastuzumab but did receive other chemotherapy and (c) HER2 negative breast cancer patients who did not receive Trastuzumab. Red center lines represent the mean of prediction scores

Back to article page

BMC Bioinformatics

ISSN: 1471-2105

Contact us